- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03917771
Early Detection of Lower Extremity Lymphedema After Lymphadenectomy in Gynecological Cancer
Study to Evaluate the Efficacy of Early Detection of Lower Extremity Lymphedema After Lymphadenectomy in Gynecological Cancer and Implantation of the Protocol
This study aims to detect and treat early lower limb lymphedema secondary to lymphadenectomy with the aim of increasing the quality of life of patients with this chronic condition.
To this end, a group of patients (treatment group) will be referred to the Rehabilitation service for a previous consultation and after surgery where lymphedema could be detected early. In addition, the usual follow-up will be carried out in Gynecology Oncology consultation (GO). In the second group, also called control, will be performed the usual follow-up in GO.
For this we randomize to one of these two groups. The research project has the favorable report of the Center's Clinical Research Ethics Committee
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
METHODOLOGY:
- Type of study: A) Randomized clinical trial B) Prospective cohort observational study
- Study period: from January 2017 to December 2017.
- Scope: health area of the province of Gipuzkoa and the University Hospital of Donostia as a reference center.
Selection of the population:
4.1. The inclusion criteria will be: A) Diagnostic gynecological cancer patients submitted to bilateral laparoscopic pelvic lymphadenectomy as laparotomics (B: Sentinel Node Biopsy study, SNB) within the usual surgical protocol, with expected survival greater than 12 weeks and adequate liver, renal and medullary functions to accept And sign informed consent 4.2. The exclusion criteria for the study will be: Blood clotting or hematological disorders, previous thromboembolic disease and history of lymphatic system disease (lymphedema or lymphocele), contraindication for physiotherapy or who do not wish to participate and / or do not sign informed consent.
4.3. Sample size: A) Assuming that according to previous studies the overall incidence of lymphedema after LPL is 21% (Hareyama et al), its estimated that a minimum sample of 44 patients will bi needed in order to be able to demonstrate at least 4-fold detection (Torres et al) of Lymphedemas with early follow-up with alpha = 0.05 and beta = 0.2, estimating that habitual follow-up detects 13% of lymphedema ( Mohler III et al).
4.4. Recruitment Process: Will be selected consecutively and offered to participate in the study.
- 5.1 Intervention: A) After diagnosis and programming for surgery at the GO consultation, circometry is performed by a trained nurse. During the admission, the nurse delivers and explains recommendations sheet and is offered to participate in the clinical trial giving him the Informed Consent (IC) and Information Sheet created for this purpose. In case of accepting and signing the IC, it is randomized (total randomization) according to system of envelopes with code.
Distribution of the intervention;
- Treatment group: Face-to-face consultation in Rehabilitation for early detection of lymphedema after surgery (1,6,12 months). Lower Limb measurement and care education
- Control group: The usual follow-up will be carried out in GO consultation (0,1,6,12 months)
The pelvic lymphadenectomy will be performed by the same surgical team using a transperitoneal approach. The limits of lymph node dissection will be: the psoas muscle, laterally, the postero-medially internal iliac artery, the bifurcation of the common iliac artery cranially, where it crosses the ureter, and caudally the origin of the epigastric vessels, to level of the deep circumflex iliac vein.
B) After diagnosis and programming for surgery at the GO consultation, circometry is performed by trained and yearly nurse. During the entrance, it is delivered and explains the recommendations sheet. SNB is performed by detecting sentinel ganglion from the above mentioned areas according to the protocol of the service. The usual follow-up will be carried out in GO consultation (0,1,6,12 months)
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Gipuzkoa
-
San Sebastián, Gipuzkoa, Spain, 20014
- Donostia Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- A) Diagnostic gynecological cancer patients submitted to bilateral laparoscopic pelvic lymphadenectomy as laparotomics (B: Sentinel Node Biopsy study, SNB) within the usual surgical protocol, with expected survival greater than 12 weeks and adequate liver, renal and medullary functions to accept And sign informed consent
Exclusion Criteria:
- The exclusion criteria for the study will be: Blood clotting or hematological disorders, previous thromboembolic disease and history of lymphatic system disease (lymphedema or lymphocele), contraindication for physiotherapy or who do not wish to participate and / or do not sign informed consent.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Early lymphedema detection
Face-to-face consultation in Rehabilitation for early detection of lymphedema after surgery.
Lower Limb measurement and care education
|
Face-to-face consultation in Rehabilitation for early detection of lymphedema after surgery (1,6,12 months).
Lower Limb measurement and care education
|
Active Comparator: Usual follow-up
The usual follow-up will be carried out in GO consultation (0,1,6,12 months)
|
Usual follow-up carried out in GO consultation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Efficacy of the implantation of a standardized postoperative follow-up for the early detection of lymphedema secondary to lymphadenectomy in gynecological cancer
Time Frame: 12 months
|
Lower Limb measurement secondary to lymphadenectomy in gynecological cancer
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Implementation of educational strategy for patients and professionals
Time Frame: 12 months
|
Care education questionnaire results
|
12 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: IBON JAUNARENA, Hospital Donostia
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IJM-EDL- 2017-01
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lymphedema of Limb
-
Lymphatica Medtech SATerminatedLymphedema of Upper Limb | Lymphedema, Secondary | Lymphedema, Lower Limb | Lymphedema of Leg | Lymphedema ArmSwitzerland
-
Maastricht University Medical CenterRadboud University Medical Center; Erasmus Medical CenterRecruitingLymphedema of Upper Limb | Lymphedema, Secondary | Lymphedema, Lower Limb | Lymphedema of Leg | Lymphedema ArmNetherlands
-
University of OttawaMcGill University; Horizon Health Network; University of New Brunswick; New Brunswick...UnknownLymphedema of Upper Limb | Mastectomy Related Lymphedema | Lymphedema of Lower Extremity
-
ResMedCompleted
-
ThuasneNot yet recruitingLymphedema of Upper LimbTurkey
-
Maastricht University Medical CenterCompleted
-
ResMedLymphatic Solutions, LLCCompletedLymphedema | Lymphedema, Secondary | Lymphedema, Lower Limb | Lymphedema of Leg | Lymphedema PrimaryUnited States
-
Riphah International UniversityRecruitingLymphedema of Upper LimbPakistan
-
Odense University HospitalDanish Cancer SocietyActive, not recruitingPathologic Processes | Neoplasms | Skin Diseases | Lymphatic Diseases | Postoperative Complications | Breast Cancer | Breast Diseases | Lymphedema | Breast Neoplasm | Surgery | Secondary Lymphedema | Breast Cancer Lymphedema | Lymphedema, Breast Cancer | Lymphedema of Upper Limb | Lymphedema Arm | Iatrogenic Lymphedema | A... and other conditionsDenmark
-
Selcuk UniversityRecruiting
Clinical Trials on Early lymphedema detection
-
Yale UniversityNational Institute of Mental Health (NIMH); Harvard UniversityCompletedSchizophrenia | PsychosisUnited States
-
Massachusetts General HospitalNational Cancer Institute (NCI)UnknownOvarian CancerUnited States
-
Zhujiang HospitalGuangzhou Burning Rock Dx Co., Ltd.RecruitingIntracranial TumorsChina
-
Drexel UniversityUniversity of California, Davis; University of ConnecticutActive, not recruitingAutism Spectrum DisorderUnited States
-
Sun Yat-sen UniversityGuangzhou Burning Rock Dx Co., Ltd.Recruiting
-
ClearNote HealthNot yet recruitingPancreatic CancerUnited States
-
Sixth Affiliated Hospital, Sun Yat-sen UniversityShanghai Weihe Medical Laboratory Co., Ltd.Not yet recruitingPRediction Of Five Usual Tumors Using Blood Test for Risk Assessment and Early Detection (PROFUTURE)Neoplasms | CancerChina
-
GRAIL, LLCRecruitingCancer | Early Detection of CancerUnited States, Canada
-
Cancer Institute and Hospital, Chinese Academy...Guangzhou Burning Rock Dx Co., Ltd.Recruiting
-
Cancer Institute and Hospital, Chinese Academy...Guangzhou Burning Rock Dx Co., Ltd.Recruiting